Therefore, to investigate the effects of PCSK9 inhibitors on CAC progression, we performed a calcium score analysis of the randomized control study comparing PCSK9 inhibitors vs. standard statin therapy in patients with coronary artery disease. This evidence concerns the gene PCSK9 and coronary artery disorder.